Aquestive Therapeutics
NDC Database

Aquestive Therapeutics

NDC Database

National Drug Code (NDC) records including drug products, NDC numbers, nonproprietary names, dosage forms, strengths, labelers and marketing information.

Drug for Further Processing
  • Total Records 3
  • Latest Marketing Date 2025-12-05
  • Data Source FDA
  • First Marketing Date 2022-02-02
Company Overview

Company

Aquestive Therapeutics

Country

U.S.A

Website

Visit Website

Email

Social Profiles

LinkedIn
Company Snapshot

Aquestive Therapeutics

30 Technology Drive Warren, NJ 07059

U.S.A

aquestive.com/ View on Map
NDC Records ( 3 records )
2025
05 Dec
Drug for Further Processing NDC: 10094-355

Nonproprietary Name

Riluzole Oral

Dosage Form

FILM

Strength

50 mg/1

Labeler

Aquestive Therapeutics

Marketing Category

EXPORT ONLY

10094-355

Substance

RILUZOLE

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2025-12-05

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2022
02 Feb
Drug for Further Processing NDC: 10094-604

Nonproprietary Name

ondansetron oral

Dosage Form

FILM

Strength

4 mg/1

Labeler

Aquestive Therapeutics

Marketing Category

EXPORT ONLY

10094-604

Substance

ONDANSETRON

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-02-02

End Marketing Date

-

Listing Record Certified Through

2027-12-31

2022
02 Feb
Drug for Further Processing NDC: 10094-608

Nonproprietary Name

ondansetron oral film

Dosage Form

FILM

Strength

8 mg/1

Labeler

Aquestive Therapeutics

Marketing Category

EXPORT ONLY

10094-608

Substance

ONDANSETRON

Product Type

DRUG FOR FURTHER PROCESSING

DEA Schedule

Start Marketing Date

2022-02-02

End Marketing Date

-

Listing Record Certified Through

2027-12-31

Related Databases
  • FDA Inspections
    6 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    3 View
  • FDA Approved Drugs Database
    3 View
  • Drug Prices in Switzerland
    0 View
NDC Type Breakdown
3 total
  • Drug for Further Processing
Official Source

NDC data is based on publicly available National Drug Code information from the U.S. Food and Drug Administration (FDA).

Visit FDA NDC Directory
NDC Record Details Preview

Explore important National Drug Code information available in the records above.

NDC

10094-355

Nonproprietary Name

Riluzole Oral

Labeler

Aquestive Therapeutics

Dosage Form

FILM

FDA NDC Data

National Drug Code information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized NDC records

NDC data is based on publicly available U.S. Food and Drug Administration (FDA) National Drug Code information.

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit